United States · FDA National Drug Code directory

euqate nicotine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
79903-101_012bcc52-fb21-4b53-9bed-aa144d6d9ee3
Product NDC
79903-101
Form
LOZENGE
Composition / generic term
Nicotine Polacrilex
Labeler
WALMART INC.
Marketing category
ANDA
Marketing start / end (source format)
20220111
Source listing expiry
20261231

Source-listed ingredients

  • NICOTINE — 2 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 CONTAINER in 1 CARTON (79903-101-20) / 20 LOZENGE in 1 CONTAINER · 79903-101-20
  • 40 LOZENGE in 1 CONTAINER (79903-101-40) · 79903-101-40
  • 2 CONTAINER in 1 CARTON (79903-101-80) / 40 LOZENGE in 1 CONTAINER · 79903-101-80

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →